Effect of pegylated interferon treatments for chronic active hepatitis C on quality of life

Alpat S., Usluer G., Yavuz H., Kartal E., ERBEN N., Bal C., ...Daha Fazla

JOURNAL OF CHEMOTHERAPY, cilt.20, sa.1, ss.101-105, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 1
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1179/joc.2008.20.1.101
  • Dergi Adı: JOURNAL OF CHEMOTHERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.101-105
  • Anahtar Kelimeler: chronic hepatitis C, health related quality of life, pegylated interferon, PLUS RIBAVIRIN, INITIAL TREATMENT, COMBINATION, IMPACT, VIRUS
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Health-related quality of life (HRQoL) during therapy was found to be improved in patients treated with peginterferon alpha-2a compared to patients receiving interferon alpha-2a. This study aimed to assess the effect of different pegylated interferon therapies used in the treatment of patients with chronic hepatitis C on HRQoL.